Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Shares Outstanding (Weighted Average) (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $34.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 14.35% year-over-year to $34.8 million, compared with a TTM value of $34.8 million through Sep 2025, up 14.35%, and an annual FY2024 reading of $31.1 million, up 33.17% over the prior year.
  • Shares Outstanding (Weighted Average) was $34.8 million for Q3 2025 at Rockwell Medical, up from $34.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $34.8 million in Q3 2025 and bottomed at $8.5 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $20.6 million, with a median of $18.5 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) plummeted 88.73% in 2021, then soared 114.88% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $8.5 million in 2021, then surged by 67.77% to $14.3 million in 2022, then soared by 63.05% to $23.3 million in 2023, then soared by 33.17% to $31.1 million in 2024, then grew by 12.1% to $34.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for RMTI at $34.8 million in Q3 2025, $34.2 million in Q2 2025, and $34.1 million in Q1 2025.